The Williams Formula 1 team has appointed a new non-executive director to its board in the form of American healthcare executive Brad Hollinger.
Hollinger is currently the team's second largest stakeholder behind co-founder Frank Williams, after he purchased Toto Wolff's remaining five per cent holding in the team earlier this year, bringing the Vibra Healthcare CEO's total holding to 15 per cent.
Hollinger joins current non-executive directors Nick Rose and Eddie Charlton on an initial three-year term.
"I'm honoured to be appointed to the Board of one of the world's legendary motorsport teams," said Hollinger. "I have tremendous faith in the potential of this business – both as a competitive Formula 1 team and diversified Advanced Engineering business.
"It is for this reason that I have invested in Williams over the past two years. I look forward to working with my colleagues on the Board to continue growing Williams and help the business fulfil its potential both on and off the race track."
Mike O'Driscoll, Williams group CEO, added: "Brad is extremely knowledgeable about Formula 1 and as a long-time fan of Williams has a tremendous passion for our team.
"His appointment adds to what is a very strong team of Non-Executive Directors who provide the company and our shareholders with the highest standards of leadership and governance."
